All In MedTech

FDA Clearance Tracker · K221188

ZEPTO Precision Capsulotomy System

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jun 23, 2022 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jun 23, 2022

Substantially Equivalent

Time to decision

59 days

Received Apr 25, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K221188
Device name
ZEPTO Precision Capsulotomy System
Applicant location
Carlsbad, CA
Received
Apr 25, 2022
Decided
Jun 23, 2022
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 886.4100
Specialty
Ophthalmology

Every decision under product code PUL

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PUL. The earliest in FDA's data is K170655, decided Jun 2, 2017.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Centricity Vision, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.